Cannabinoids for treatment of Alzheimer’s disease: moving towards the clinic

by Isidro eFerrer
Published 2014-03-01

CB2 cannabinoid receptor as potential target against Alzheimer’s disease

by Ester eAso, Isidro eFerrer
Published 2016-05-01

Subtype and regional-specific neuroinflammation in sporadic Creutzfeldt-Jakob disease

by Franc eLlorens, Irene eLopez-Gonzalez, Katrin eThüne, Margarita eCarmona, Saima eZafar, Olivier eAndreóletti, Inga eZerr, Isidro eFerrer
Published 2014-08-01

DYRK1A-mediated phosphorylation of GluN2A at Ser1048 regulates the surface expression and channel activity of GluN1/GluN2A receptors

by Cristina eGrau, Krisztina eArató, Krisztina eArató, José M. Fernández-Fernández, Aitana eValderrama, Carlos eSindreu, Cristina eFillat, Cristina eFillat, Isidro eFerrer, Susana ede la Luna, Susana ede la Luna, Susana ede la Luna, Xavier eAltafaj
Published 2014-10-01